Liver involvement in patients with Gaucher disease types I and III
Background & aims: Gaucher disease (GD) is a multisystemic disease. Liver involvement in GD is not well characterised and ranges from hepatomegaly to cirrhosis and hepatocellular carcinoma. We aim to describe, and assess the effect of treatment, on the hepatic phenotype of a cohort of patients w...
Main Authors: | Rodrigo Tzovenos Starosta, Filippo Pinto e Vairo, Alícia Dorneles Dornelles, Suélen Porto Basgalupp, Marina Siebert, Maria Lúcia Alves Pedroso, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares-da-Silva, Ida Vanessa Doederlein Schwartz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426919301764 |
Similar Items
-
Efficacy and Safety of Taliglucerase Alfa for the Treatment of Gaucher Disease: A 9-Year Experience
by: Livia d’Avila Paskulin, et al.
Published: (2022-05-01) -
GBA1 variants in Brazilian Gaucher disease patients
by: Suelen Porto Basgalupp, et al.
Published: (2023-12-01) -
The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher disease
by: Tiago Koppe, et al.
Published: (2016-03-01) -
Gaucher Disease and Gaucher Cells
by: Sevgi Gözdaşoğlu
Published: (2015-05-01) -
Pulmonary involvement in siblings with Gaucher disease type III
by: Đorđević Maja, et al.
Published: (2011-01-01)